BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 25417930)

  • 1. Primaquine treatment suppresses experimental autoimmune encephalomyelitis severity.
    Zanucoli F; Thomé R; Bonfanti AP; de Carvalho AC; Issayama LK; da Costa TA; Di Gangi R; Ferreira IT; Bombeiro AL; de Oliveira AL; Verinaud L
    CNS Neurosci Ther; 2014 Dec; 20(12):1061-4. PubMed ID: 25417930
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of the selective progesterone receptor agonist Nestorone for chronic experimental autoimmune encephalomyelitis.
    Garay L; Gonzalez Deniselle MC; Sitruk-Ware R; Guennoun R; Schumacher M; De Nicola AF
    J Neuroimmunol; 2014 Nov; 276(1-2):89-97. PubMed ID: 25200475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microglia response in retina and optic nerve in chronic experimental autoimmune encephalomyelitis.
    Horstmann L; Kuehn S; Pedreiturria X; Haak K; Pfarrer C; Dick HB; Kleiter I; Joachim SC
    J Neuroimmunol; 2016 Sep; 298():32-41. PubMed ID: 27609273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The MAO inhibitor phenelzine can improve functional outcomes in mice with established clinical signs in experimental autoimmune encephalomyelitis (EAE).
    Benson CA; Wong G; Tenorio G; Baker GB; Kerr BJ
    Behav Brain Res; 2013 Sep; 252():302-11. PubMed ID: 23777648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nogo receptor complex expression dynamics in the inflammatory foci of central nervous system experimental autoimmune demyelination.
    Theotokis P; Touloumi O; Lagoudaki R; Nousiopoulou E; Kesidou E; Siafis S; Tselios T; Lourbopoulos A; Karacostas D; Grigoriadis N; Simeonidou C
    J Neuroinflammation; 2016 Oct; 13(1):265. PubMed ID: 27724971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory role of oligodendrocyte gap junctions in inflammatory demyelination.
    Papaneophytou CP; Georgiou E; Karaiskos C; Sargiannidou I; Markoullis K; Freidin MM; Abrams CK; Kleopa KA
    Glia; 2018 Dec; 66(12):2589-2603. PubMed ID: 30325069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single β³-amino acid substitutions to MOG peptides suppress the development of experimental autoimmune encephalomyelitis.
    McDonald CA; Payne NL; Sun G; Clayton DJ; Del Borgo MP; Aguilar MI; Perlmutter P; Bernard CC
    J Neuroimmunol; 2014 Dec; 277(1-2):67-76. PubMed ID: 25454728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation.
    Becquet L; Abad C; Leclercq M; Miel C; Jean L; Riou G; Couvineau A; Boyer O; Tan YV
    J Neuroinflammation; 2019 Mar; 16(1):64. PubMed ID: 30894198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-Lapachone ameliorization of experimental autoimmune encephalomyelitis.
    Xu J; Wagoner G; Douglas JC; Drew PD
    J Neuroimmunol; 2013 Jan; 254(1-2):46-54. PubMed ID: 23010281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pertussis toxin modulates microglia and T cell profile to protect experimental autoimmune encephalomyelitis.
    Yin JX; Tang Z; Gan Y; Li L; Shi F; Coons S; Shi J
    Neuropharmacology; 2014 Jun; 81():1-5. PubMed ID: 24486709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total glucosides of peony attenuates experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Huang Q; Ma X; Zhu DL; Chen L; Jiang Y; Zhou L; Cen L; Pi R; Chen X
    J Neuroimmunol; 2015 Jul; 284():67-73. PubMed ID: 26025060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex differences in central nervous system plasticity and pain in experimental autoimmune encephalomyelitis.
    Catuneanu A; Paylor JW; Winship I; Colbourne F; Kerr BJ
    Pain; 2019 May; 160(5):1037-1049. PubMed ID: 30649100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained TNF production by central nervous system infiltrating macrophages promotes progressive autoimmune encephalomyelitis.
    Valentin-Torres A; Savarin C; Hinton DR; Phares TW; Bergmann CC; Stohlman SA
    J Neuroinflammation; 2016 Feb; 13():46. PubMed ID: 26906225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artesunate Ameliorates Experimental Autoimmune Encephalomyelitis by Inhibiting Leukocyte Migration to the Central Nervous System.
    Thomé R; de Carvalho AC; Alves da Costa T; Ishikawa LL; Fraga-Silva TF; Sartori A; de Oliveira AL; Verinaud L
    CNS Neurosci Ther; 2016 Aug; 22(8):707-14. PubMed ID: 27165523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RGS10 deficiency ameliorates the severity of disease in experimental autoimmune encephalomyelitis.
    Lee JK; Kannarkat GT; Chung J; Joon Lee H; Graham KL; Tansey MG
    J Neuroinflammation; 2016 Feb; 13():24. PubMed ID: 26831924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of myelin peptide with vitamin D prevents autoimmune encephalomyelitis development.
    Mimura LA; Chiuso-Minicucci F; Fraga-Silva TF; Zorzella-Pezavento SF; França TG; Ishikawa LL; Penitenti M; Ikoma MR; Sartori A
    Neuroscience; 2016 Mar; 317():130-40. PubMed ID: 26762804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Keratan sulfate exacerbates experimental autoimmune encephalomyelitis.
    Ueno R; Miyamoto K; Tanaka N; Moriguchi K; Kadomatsu K; Kusunoki S
    J Neurosci Res; 2015 Dec; 93(12):1874-80. PubMed ID: 26340909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of iron homeostasis proteins in the spinal cord in experimental autoimmune encephalomyelitis and their implications for iron accumulation.
    Zarruk JG; Berard JL; Passos dos Santos R; Kroner A; Lee J; Arosio P; David S
    Neurobiol Dis; 2015 Sep; 81():93-107. PubMed ID: 25724358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-BFI ameliorates EAE-induced mouse spinal cord damage: effective therapeutic time window and possible mechanisms.
    Li F; Zhang ZX; Liu YF; Xu HQ; Hou ST; Zheng RY
    Brain Res; 2012 Nov; 1483():13-9. PubMed ID: 22985669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repetitive intrathecal injection of human NMO-IgG with complement exacerbates disease severity with NMO pathology in experimental allergic encephalomyelitis mice.
    Lee CL; Wang KC; Chen SJ; Chen CM; Tsai CP; Chen SY
    Mult Scler Relat Disord; 2019 May; 30():225-230. PubMed ID: 30825702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.